Cost-Effectiveness Analysis of Tisagenlecleucel for the Treatment of Pediatric and Young Adult Patients with Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia in Japan

Transplantation and Cellular Therapy ◽

10.1016/j.jtct.2020.12.023 ◽

2020 ◽

Author(s):

Shiho Wakase ◽

Takanori Teshima ◽

Jie Zhang ◽

Qiufei Ma ◽

Yoko Watanabe ◽

...

Keyword(s):

Cost Effectiveness ◽

Acute Lymphoblastic Leukemia ◽

Young Adult ◽

B Cell ◽

Lymphoblastic Leukemia ◽

Cost Effectiveness Analysis ◽

Adult Patients ◽

Effectiveness Analysis ◽

Cell Acute Lymphoblastic Leukemia

Download Full-text

PCN170 - COST-EFFECTIVENESS OF TISAGENLECLEUCEL IN PEDIATRIC AND YOUNG ADULT PATIENTS WITH RELAPSED OR REFRACTORY B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA: A CANADIAN SOCIETAL PERSPECTIVE

Value in Health ◽

10.1016/j.jval.2018.09.253 ◽

2018 ◽

Vol 21 ◽

pp. S43 ◽

Author(s):

H. Yang ◽

J. Zhang ◽

M. Hampe

Keyword(s):

Cost Effectiveness ◽

Acute Lymphoblastic Leukemia ◽

Young Adult ◽

B Cell ◽

Societal Perspective ◽

Lymphoblastic Leukemia ◽

Adult Patients ◽

Cell Acute Lymphoblastic Leukemia

Download Full-text

Efficacy and safety of tisagenlecleucel in Japanese pediatric and young adult patients with relapsed/refractory B cell acute lymphoblastic leukemia

International Journal of Hematology ◽

10.1007/s12185-019-02771-2 ◽

2019 ◽

Vol 111 (2) ◽

pp. 303-310 ◽

Author(s):

Hidefumi Hiramatsu ◽

Souichi Adachi ◽

Katsutsugu Umeda ◽

Itaru Kato ◽

Lamis Eldjerou ◽

...

Keyword(s):

Acute Lymphoblastic Leukemia ◽

Young Adult ◽

B Cell ◽

Lymphoblastic Leukemia ◽

Adult Patients ◽

Efficacy And Safety ◽

Cell Acute Lymphoblastic Leukemia

Download Full-text

Poster: ALL-190: Cost-Effectiveness of KTE-X19 for Adult Patients with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia (R/R B-ALL) in the United States

Clinical Lymphoma Myeloma & Leukemia ◽

10.1016/s2152-2650(21)01297-0 ◽

2021 ◽

Vol 21 ◽

pp. S207

Author(s):

Bijal Shah ◽

Nathaniel Smith ◽

Angie Raad ◽

Chaoling Feng ◽

Gab Castaigne ◽

...

Keyword(s):

United States ◽

Cost Effectiveness ◽

Acute Lymphoblastic Leukemia ◽

B Cell ◽

Lymphoblastic Leukemia ◽

The United States ◽

Adult Patients ◽

Cell Acute Lymphoblastic Leukemia

Download Full-text

Cost-Effectiveness Analysis of Tisagenlecleucel, Blinatumomab, and Clofarabine for Treatment of B-cell Precursor Acute Lymphoblastic Leukemia

10.36837/chapman.000294 ◽

2021 ◽

Author(s):

◽

Kamron Lotfi

Keyword(s):

Cost Effectiveness ◽

Acute Lymphoblastic Leukemia ◽

B Cell ◽

Lymphoblastic Leukemia ◽

Cost Effectiveness Analysis ◽

Cell Precursor ◽

Effectiveness Analysis

Download Full-text

ALL-190: Cost-Effectiveness of KTE-X19 for Adult Patients with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia (R/R B-ALL) in the United States

Clinical Lymphoma Myeloma & Leukemia ◽

10.1016/s2152-2650(21)01658-x ◽

2021 ◽

Vol 21 ◽

pp. S272-S273

Author(s):

Bijal Shah ◽

Nathaniel Smith ◽

Angie Raad ◽

Chaoling Feng ◽

Gab Castaigne ◽

...

Keyword(s):

United States ◽

Cost Effectiveness ◽

Acute Lymphoblastic Leukemia ◽

B Cell ◽

Lymphoblastic Leukemia ◽

The United States ◽

Adult Patients ◽

Cell Acute Lymphoblastic Leukemia

Download Full-text

Survival after stem-cell transplant in pediatric and young-adult patients with relapsed and refractory B-cell acute lymphoblastic leukemia

Current Medical Research and Opinion ◽

10.1080/03007995.2017.1384373 ◽

2017 ◽

Vol 34 (3) ◽

pp. 435-440 ◽

Author(s):

Alessandro Crotta ◽

Jie Zhang ◽

Christopher Keir

Keyword(s):

Stem Cell ◽

Acute Lymphoblastic Leukemia ◽

Young Adult ◽

B Cell ◽

Stem Cell Transplant ◽

Lymphoblastic Leukemia ◽

Adult Patients ◽

Cell Transplant ◽

Cell Acute Lymphoblastic Leukemia

Download Full-text

PCN142 - COST-EFFECTIVENESS ANALYSIS OF INOTUZUMAB OZOGAMICIN FOR THE TREATMENT OF ADULTS WITH RELAPSED OR REFRACTORY B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA IN BULGARIA

Value in Health ◽

10.1016/j.jval.2018.09.225 ◽

2018 ◽

Vol 21 ◽

pp. S38

Author(s):

S. Djambazov ◽

G. Slavchev ◽

M. Encheva-Malinova ◽

V. Varbanova ◽

M. Velchev ◽

...

Keyword(s):

Cost Effectiveness ◽

Acute Lymphoblastic Leukemia ◽

B Cell ◽

Lymphoblastic Leukemia ◽

Cost Effectiveness Analysis ◽

Cell Precursor ◽

Inotuzumab Ozogamicin ◽

Effectiveness Analysis

Download Full-text

Fluconazole versus mould-active triazoles for primary antifungal prophylaxis in adult patients with acute lymphoblastic leukemia: clinical outcome and cost-effectiveness analysis

International Journal of Hematology ◽

10.1007/s12185-017-2342-x ◽

2017 ◽

Vol 107 (2) ◽

pp. 235-243

Author(s):

Yan Wang ◽

Yuanming Xing ◽

Lu Chen ◽

Ti Meng ◽

Ying Li ◽

...

Keyword(s):

Cost Effectiveness ◽

Acute Lymphoblastic Leukemia ◽

Clinical Outcome ◽

Lymphoblastic Leukemia ◽

Antifungal Prophylaxis ◽

Cost Effectiveness Analysis ◽

Adult Patients ◽

Effectiveness Analysis

Download Full-text

PIH8 Cost-Effectiveness Analysis Of Dasatinib Versus Imatinib In Treating Pediatric Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Patients In China

Value in Health ◽

10.1016/j.jval.2021.04.526 ◽

2021 ◽

Vol 24 ◽

pp. S100

Author(s):

W. Cao ◽

Y. Yu ◽

L. Shi ◽

Y. Qiu ◽

H. Zhang ◽

...

Keyword(s):

Cost Effectiveness ◽

Acute Lymphoblastic Leukemia ◽

Lymphoblastic Leukemia ◽

Philadelphia Chromosome ◽

Cost Effectiveness Analysis ◽

Effectiveness Analysis ◽

Philadelphia Chromosome Positive

Download Full-text

CRLF2-Positive B-Cell Acute Lymphoblastic Leukemia in Adult Patients

American Journal of Clinical Pathology ◽

10.1093/ajcp/aqx005 ◽

2017 ◽

Vol 147 (4) ◽

pp. 357-363 ◽

Author(s):

Sergej Konoplev ◽

Xinyan Lu ◽

Marina Konopleva ◽

Nitin Jain ◽

Juan Ouyang ◽

...

Keyword(s):

Acute Lymphoblastic Leukemia ◽

B Cell ◽

Lymphoblastic Leukemia ◽

Adult Patients ◽

Cell Acute Lymphoblastic Leukemia

Download Full-text